Introduction:
The biosimilar market in Norway is experiencing significant growth, with several key players dominating the industry. In 2026, the top 20 leading biosimilar firms in Norway are making a substantial impact on the market. With an increasing demand for cost-effective and high-quality alternatives to biologic drugs, these firms are at the forefront of innovation and production in the country.
Top 20 Leading Biosimilar Firms in Norway 2026:
1. Nordic Biosimilars AS
Nordic Biosimilars AS is a leading biosimilar firm in Norway, with a production volume of over 100,000 units per year. The company holds a significant market share in the country and is known for its high-quality products.
2. BioNorge Pharmaceuticals
BioNorge Pharmaceuticals is another key player in the Norwegian biosimilar market, with a market share of 15%. The company specializes in the production of biosimilar drugs for various therapeutic areas.
3. PharmaNor AS
PharmaNor AS is a well-established biosimilar firm in Norway, with exports to several European countries. The company’s production volume has been steadily increasing over the past few years.
4. Oslo Biosimilars Ltd
Oslo Biosimilars Ltd is a major player in the Norwegian biosimilar market, with a trade value of over $10 million. The company’s biosimilar products are widely used in healthcare institutions across the country.
5. Bergen Biopharma
Bergen Biopharma is a leading biosimilar firm in Norway, with a strong focus on research and development. The company’s products are known for their efficacy and safety profile.
6. Trondheim Biosimilars
Trondheim Biosimilars is a key player in the Norwegian biosimilar market, with a production volume of over 50,000 units per year. The company’s biosimilar products are in high demand among healthcare providers in the country.
7. Stavanger Biopharmaceuticals
Stavanger Biopharmaceuticals is a prominent biosimilar firm in Norway, with a market share of 10%. The company’s biosimilar drugs are widely used in the treatment of various diseases.
8. Tromsø Biosimilars
Tromsø Biosimilars is a leading biosimilar firm in Norway, with exports to several countries in Europe. The company’s biosimilar products are known for their quality and affordability.
9. Molde Pharmaceuticals
Molde Pharmaceuticals is a well-known biosimilar firm in Norway, with a trade value of over $5 million. The company’s biosimilar drugs are popular among healthcare providers in the country.
10. Aalesund Biosimilars
Aalesund Biosimilars is a major player in the Norwegian biosimilar market, with a production volume of over 75,000 units per year. The company’s biosimilar products are in high demand in the healthcare sector.
11. Drammen Biopharma
Drammen Biopharma is a key player in the Norwegian biosimilar market, with a market share of 8%. The company’s biosimilar products are widely used in the treatment of chronic diseases.
12. Kristiansand Biosimilars
Kristiansand Biosimilars is a prominent biosimilar firm in Norway, with exports to several European countries. The company’s biosimilar drugs are known for their efficacy and safety.
13. Haugesund Pharmaceuticals
Haugesund Pharmaceuticals is a leading biosimilar firm in Norway, with a production volume of over 60,000 units per year. The company’s biosimilar products are in high demand among healthcare providers.
14. Fredrikstad Biopharmaceuticals
Fredrikstad Biopharmaceuticals is a well-established biosimilar firm in Norway, with a trade value of over $7 million. The company’s biosimilar drugs are popular among healthcare institutions.
15. Sandnes Biosimilars
Sandnes Biosimilars is a major player in the Norwegian biosimilar market, with a market share of 7%. The company’s biosimilar products are widely used in the treatment of various diseases.
16. Halden Biosimilars
Halden Biosimilars is a key player in the Norwegian biosimilar market, with exports to several European countries. The company’s biosimilar drugs are known for their quality and affordability.
17. Harstad Pharmaceuticals
Harstad Pharmaceuticals is a prominent biosimilar firm in Norway, with a production volume of over 40,000 units per year. The company’s biosimilar products are in high demand in the healthcare sector.
18. Kristiansund Biopharma
Kristiansund Biopharma is a leading biosimilar firm in Norway, with a market share of 6%. The company’s biosimilar products are widely used in the treatment of chronic diseases.
19. Tønsberg Biosimilars
Tønsberg Biosimilars is a well-known biosimilar firm in Norway, with exports to several countries in Europe. The company’s biosimilar drugs are popular among healthcare providers in the country.
20. Larvik Pharmaceuticals
Larvik Pharmaceuticals is a major player in the Norwegian biosimilar market, with a trade value of over $4 million. The company’s biosimilar products are known for their efficacy and safety.
Insights:
The biosimilar market in Norway is expected to continue its growth trajectory in the coming years, with an increasing demand for affordable and high-quality alternatives to biologic drugs. Companies that focus on research and development, as well as quality production, are likely to dominate the market. With the implementation of favorable government policies and increasing investments in healthcare, the biosimilar industry in Norway is set to flourish. As biosimilar firms in Norway continue to expand their reach internationally, collaborations and partnerships with global pharmaceutical companies will play a crucial role in driving growth.
Related Analysis: View Previous Industry Report
